A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
Peyronnet B, Mironska E, Chapple C, Cardozo L, Oelke M, Dmochowski R, Amarenco G, Gamé X, Kirby R, Van Der Aa F, Cornu JN.
Eur Urol. 2019 Jun;75(6):988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26.
PMID:30922690
Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity.
Kaviani A, Khavari R.
Urol Clin North Am. 2017 Aug;44(3):463-474. doi: 10.1016/j.ucl.2017.04.012.
PMID:28716326
Intradetrusor botulinum toxin as the first-line treatment for neurogenic detrusor overactivity: Cons.
Del Popolo G, Gemma L.
Prog Urol. 2023 Mar;33(4):176-177. doi: 10.1016/j.purol.2022.12.008. Epub 2023 Jan 2.
PMID:36599798
Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review.